Chitosan Covalently Functionalized with Peptides Mapped on Vitronectin and BMP-2 for Bone Tissue Engineering

Bone disorders affect millions globally, creating a need for safe and effective tissue repair solutions. Traditional scaffolds aim to support tissue regeneration without harmful effects. Chitosan, a natural polymer, has gained attention for its biocompatibility and ability to support bone growth. However, its full potential remains underexplored. Researchers have started modifying chitosan with bioactive molecules to improve its performance. These modifications aim to enhance cell interaction and tissue regeneration. Despite progress, the specific effects of peptide-functionalized chitosan remain unclear. This gap motivated the current study to test two bioactive peptides. The goal is to determine how these peptides influence osteoblast behavior on chitosan scaffolds.

The study aimed to evaluate how chitosan scaffolds functionalized with specific peptides impact osteoblast behavior. Vitronectin and BMP-2 peptides were selected for their roles in cell adhesion and differentiation. The researchers hypothesized that these peptides could improve scaffold performance. They wanted to assess adhesion, proliferation, and differentiation of osteoblasts on modified scaffolds. The experiment focused on comparing two modified chitosan variants: Chit-HVP and Chit-GBMP1a. These scaffolds were tested for their ability to support bone cell functions. The study sought to determine whether peptide grafting enhances osteoblast activity. The findings could inform the design of improved bone tissue engineering materials.

The study used covalent grafting to attach peptides to chitosan. Nuclear magnetic resonance (NMR) confirmed the chemical structure of modified chitosan. X-ray photoelectron spectroscopy (XPS) and Fourier transform infrared spectroscopy (FT-IR) verified peptide attachment. The modified scaffolds were named Chit-HVP and Chit-GBMP1a based on their functional peptides. Human osteoblasts were cultured on these scaffolds to assess biological responses. The experiments measured adhesion, proliferation, and calcium deposition. Gene expression of key osteoblast proteins was also analyzed. The methods combined material characterization with in vitro cell studies to evaluate scaffold performance.

The modified chitosan scaffolds showed successful peptide grafting confirmed by NMR, XPS, and FT-IR. Chit-HVP significantly improved osteoblast adhesion and proliferation. Chit-GBMP1a enhanced cell differentiation toward an osteoblastic phenotype. Both scaffolds supported calcium deposition and gene expression of key proteins. Chit-HVP demonstrated stronger effects on cell adhesion and growth. Chit-GBMP1a showed a more pronounced influence on differentiation markers. The results suggest that peptide selection affects scaffold functionality. These findings indicate that functionalized chitosan can support bone tissue regeneration.

The study demonstrated that chitosan scaffolds functionalized with specific peptides can influence osteoblast behavior. Chit-HVP improved adhesion and proliferation, while Chit-GBMP1a enhanced differentiation. The results suggest that peptide grafting can tailor scaffold properties for tissue engineering. The authors propose that these findings support the use of functionalized chitosan in bone regeneration. The study highlights the importance of peptide selection in scaffold design. The findings align with the goal of creating biocompatible materials for bone tissue engineering. The authors suggest that these modified scaffolds may offer advantages over unmodified chitosan. The study contributes to understanding how peptide-functionalized materials affect cell behavior.